Harbour BioMed
Harbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer.
Launch date
Employees
Market cap
€91.2m
Enterprise valuation
€28m (Public information from Sep 2024)
Share price
HKD1.23 2142.HK
Cambridge Massachusetts (HQ)
Authorizing premium user...